Initial clinical experience using a novel Pd-103 surface applicator for the treatment of retroperitoneal and abdominal wall malignancies.

A slight trend of CivaDot clustering was observed on the CT scan performed 86 days after implant in patient 1; the bioabsorbable membrane starts to deform and disintegrate after 6 to 8 weeks, according to the manufacturer.

also in 4,078 other papers